Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U2 small nuclear 70, pseudogene (RNU2-70P) is a genetic locus classified as a pseudogene that resembles the gene encoding U2 small nuclear RNA but lacks coding potential and is not believed to produce a functional RNA product[1][5][9]. True U2 snRNA genes play an essential role in the spliceosome—the complex responsible for splicing precursor mRNA in eukaryotes[2][6]. In contrast, RNU2-70P is non-functional: it may retain partial sequence similarity and be flanked by direct repeat sequences, but it is generally truncated and lacks critical regions required for producing mature U2 snRNA[8][5]. There is no evidence that RNU2-70P is transcribed into a functional snRNA, involved in any biological process, or associated with any disease or therapeutic role[9]. RNU2-70P should not be confused with functional small nuclear RNA genes such as RNU2-1 or RNU2-2, which are involved in mRNA splicing and, in rare cases, associated with neurodevelopmental disorders when mutated[3][7][10]. Key notes: - This locus is not a therapeutic target, receptor, or functional gene. - The name is correctly spelled, but the entity is not suitable for drug target analysis. - No evidence exists for biological, pharmacological, or disease relevance for RNU2-70P[9]. If you require information on U2 small nuclear RNA (e.g., RNU2-1, RNU2-2)—which are functional targets involved in splicing—please clarify, as these have entirely different biological and disease roles[2][3][10].
None (no drugs or biologics reported to act via this locus)[9]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U2 small nuclear 70, pseudogene (RNU2-70P).